Nazione: Stati Uniti
Lingua: inglese
Fonte: NLM (National Library of Medicine)
XANTHIUM STRUMARIUM POLLEN (UNII: 2QOF601J1M) (XANTHIUM STRUMARIUM POLLEN - UNII:2QOF601J1M), PLANTAGO LANCEOLATA POLLEN (UNII: DO87T1U2CI) (PLANTAGO LANCEOLATA POLLEN - UNII:DO87T1U2CI), CHENOPODIUM ALBUM POLLEN (UNII: 098LKX5NCN) (CHENOPODIUM ALBUM POLLEN - UNII:098LKX5NCN), AMARANTHUS RETROFLEXUS POLLEN (UNII: 73B14PX5FW) (AMARANTHUS RETROFLEXUS POLLEN - UNII:73B14PX5FW)
ALK-Abello, Inc.
PERCUTANEOUS
These products are for diagnostic use only. Diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. By measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. For extracts standardized in AU and BAU, see individual directions for use. Allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. Patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed WARNING statement and ADVERSE REACTIONS ). The physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. Patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater
For scratch and prick testing: 5 mL dropper applicator vials in 50% v/v glycerin or 10mL stoppered vial in 50% v/v glycerin. Available individually and in a complete set of the most common allergens. Available in either Protein Nitrogen Units (PNU/mL) or weight to volume (w/v). For intracutaneous testing: 5 mL sterile vials, aqueous based, individually and in a complete set of the most common allergens. Available in either Protein Nitrogen Units (PNU/mL) or weight to volume (w/v). Histatrol ® Positive skin test control - histamine. 1 mg/mL and 0.1 mg/mL histamine base. See Product Catalog for specific diagnostic concentrations available.
Biologic Licensing Application
4 WEED MIX- AMARANTHUS RETROFLEXUS POLLEN, CHENOPODIUM ALBUM POLLEN, PLANTAGO LANCEOLATA POLLEN AND XANTHIUM STRUMARIUM POLLEN INJECTION, SOLUTION 9 TREE MIX- ACER SACCHARUM POLLEN, ALNUS RHOMBIFOLIA POLLEN, BETULA LENTA POLLEN, CARYA OVATA POLLEN, FRAXINUS AMERICANA POLLEN, PLATANUS OCCIDENTALIS POLLEN, POPULUS ALBA POLLEN, QUERCUS ALBA POLLEN AND ULMUS CRASSIFOLIA POLLEN INJECTION, SOLUTION BIRCH MIX- BETULA NIGRA POLLEN AND BETULA POPULIFOLIA POLLEN INJECTION, SOLUTION HICKORY/ PECAN MIX- CARYA ILLINOINENSIS POLLEN AND CARYA OVATA POLLEN INJECTION, SOLUTION MAPLE/BOX ELDER- ACER NEGUNDO POLLEN AND ACER SACCHARUM POLLEN INJECTION, SOLUTION MAPLE MIX- ACER NEGUNDO POLLEN AND ACER RUBRUM POLLEN INJECTION, SOLUTION MIXED COCKROACH- BLATELLA GERMANICA AND PERIPLANETA AMERICANA INJECTION, SOLUTION MIXED FEATHERS- ANAS PLATYRHYNCHOS FEATHER, ANSER ANSER FEATHER AND GALLUS GALLUS FEATHER INJECTION, SOLUTION MIXED WEEDS- CHENOPODIUM ALBUM POLLEN, IVA ANNUA POLLEN, PLANTAGO LANCEOLATA POLLEN AND XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN INJECTION, SOLUTION OAK MIX- QUERCUS ALBA POLLEN, QUERCUS RUBRA POLLEN AND QUERCUS VIRGINIANA POLLEN INJECTION, SOLUTION SALIX NIGRA POLLEN- WILLOW BLACK INJECTION, SOLUTION MOSQUITO- CULIX PIPIENS INJECTION, SOLUTION DANDELION- TARAXACUM OFFICINALE POLLEN INJECTION, SOLUTION NETTLE- URTICA DIOICA POLLEN INJECTION, SOLUTION SHORT RAGWEED- AMBROSIA ARTEMISIIFOLIA INJECTION, SOLUTION ALK-ABELLO, INC. ---------- SCRATCH NONSTANDARDIZED PRODUCTS ALLERGENIC EXTRACTS, FOR DIAGNOSTIC USE ONLY DIRECTIONS FOR USE WARNING This product is intended for use by physicians who are experienced in the administration of allergenic extracts and the emergency care of anaphylaxis, or for use under the guidance of an allergy specialist. As with all allergenic extracts, severe systemic reactions may occur. In certain individuals these life-threatening reactions may result in death. Fatalities associated with skin testing have been reported. Patients should be observed for at least 20 - 30 minutes following tes Leggi il documento completo